The R&D digital transformation (DX) landscape is evolving once again—driven by the rise of generative AI and now AI agents—and budgets need to keep pace. Enthought Chief Operating Officer Michael Connell shares his thoughts via pharmaphorum on how R&D leaders should think about their DX budgets today as pressure increases to deliver measurable outcomes.
Key Takeaways:
- Recalibrate ROI expectations between digital enhancements and digital transformation
- Have a centralized authority who owns the R&D digital transformation budget vs. distributing among siloed business units focused on short-term outcomes
- Establish clear decision-making mechanisms for budget allocation
Read the full interview at pharmaphorum here.
Additional resources about AI and ML in scientific research here.
